Figure 1.

Vitamin D level distribution over 1 year among the schizophreniform and autism spectrum disorder groups. Five patients reached recommended levels >30 ng/ml: patient 1: 43 years, female, schizophreniform syndrome (organic schizophreniform disorder), treated with olanzapine, body mass index (BMI) of 26.7 kg/m²; patient 2: 25 years, male, autism spectrum disorder (Asperger syndrome), no psychiatric medication, BMI of 19.4 kg/m²; patient 3: 41 years, male, autism spectrum disorder (atypical autism), treated with olanzapine and clomipramine, BMI of 23.7 kg/m²; patient 4: 37 years, male, schizophreniform syndrome (schizophrenia), treated with olanzapine and escitalopram, BMI of 25.6 kg/m²; patient 5: 21 years, male, schizophreniform syndrome (schizoaffective disorder), treated with quetiapine and venlafaxine, BMI of 26.4 kg/m².